DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Sanofi India Limited — Board Meeting Intimation

NSE 18 hrs ago·20 Jul 2026, 6:54 am

Sanofi India

Sanofi India has announced a scheduled board meeting for August 4, 2026. The primary agenda for this meeting is to review and approve the company's unaudited financial results for the first half of the fiscal year ending June 2026.

This announcement is a routine corporate procedure that signals the upcoming release of key financial data. For investors, the focus will be on the company's performance metrics, including revenue growth, profit margins, and operational efficiency for the interim period.

Investors should wait for the official release of these results to assess the company's current financial health. The data will provide insights into the company's trajectory and help in making informed investment decisions.